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ABSTRACT
Objectives: To see the association between weight loss and anxiety, depression after percutaneous transluminal coronary angioplasty (PTCA) for 
coronary artery disease patients. (1) To see the severity of anxiety and depression 1 month after PTCA, (2) to evaluate the relationship between the 
weight changes and major adverse cardiac events (MACE) in 1 month follow-up. 
Methods: A total 1001 patients who underwent PTCA for acute coronary syndrome and coronary heart disease were included. Data were collected 
at baseline and 1 month after PTCA. A validated Euro 5Q-5D-5L questionnaire was used to assess the level of anxiety and depression. Chi-square test 
was applied to find out the association between weight loss status and anxiety, depression.
Results: There was a significant decrease in mean weight 1 month after coronary angioplasty (64.18±11.022 vs. 61.96±11.17, p<0.001). No association 
was observed between weight loss status and anxiety, depression in PTCA patients (p=0.5) and there is no significant association between weight 
changes and MACE 1 month after PTCA (p=0.92).
Conclusion: Data show that anxiety and depression were observed in 64.9% of the study population after coronary angioplasty but anxiety and 
depression are not associated with weight loss after PTCA. Loss of weight may be due to the modified post angioplasty lifestyles such as adherent 
to Mediterranean diet, physical exercise, cessation of smoking, optimum control of blood pressure, blood sugar, and blood cholesterol along with 
prescribed medications. Anxiety and depression may turn into chronic stage if not treated wisely could lead to significant MACE. Proper pre-hospital 
discharge counseling is necessary for all post PTCA patients to sustain their quality of life.
Keywords: Percutaneous transluminal coronary angioplasty, Weight loss, Anxiety, Depression.
INTRODUCTION
Maintaining healthy weight is one of the major concerns among 
the people. Increased body weight, being overweight, and obesity 
are considered as major risk factor for the acute myocardial 
infarction (AMI) [1]. American college of cardiology, American heart 
association and cardiologic societies recommend early detection 
wherein management of obesity is necessary for primary prevention 
because of the greater risk for adverse cardiac events and all-cause 
mortality in coronary artery disease (CAD) [2,3]. There are many 
pathophysiological pathways by which obesity increases the risk for 
developing CAD and adverse cardiovascular events. Obesity reduces 
insulin sensitivity, enhances free fatty acid turnover, increases basal 
sympathetic tone, induces a hypercoagulable state, and promotes 
systemic inflammation, all of which contribute to the development 
and progression of CAD [4].
There are different modalities for losing weight, for example, 
starvation, liquid protein diets, very low-calorie diets, and even obesity 
surgeries [5]. Intentional and unintentional weight loss in post MI was 
observed, but there is no definite explainable mechanism for the loss of 
weight. Intentional weight loss, viz., switching into Mediterranean diet, 
use of omega-3 fatty acids, low cholesterol and low fatty acids diets, 
regular physical exercise, optimum control of blood sugar, and blood 
pressure may be protective in patients with CAD [6,7]
Unintentional weight loss also noted in post-operative surgeries 
including coronary artery bypass graft (CABG) surgeries and it is 
considered that restriction in the caloric intake in the post-operative 
period is vital cause for weight loss [8]. Apart from the surgeries there 
is an evidence of decreased weight in non-invasive procedure like 
percutaneous transluminal coronary angioplasty (PTCA) for CAD along 
with improved diet and exercise [9]. However, some effects were found 
on the different psychological variables, as well as on morbidity or 
return to work.
Depression and anxiety are common outcome after PTCA and have been 
linked with weight changes in the general population [10]. In animals, 
social isolation contributes to weight loss, and this may happen in 
humans [11,12] asocial isolation is associated with worse outcomes 
after MI.
Unlike other psychosocial factors, depression and anxiety represent 
well-defined psychiatric disorders and they are important cause of 
coronary heart disease. Depression and coronary heart disease could 
share common backgrounds, for example, environmental stressors 
and social supports. Depressive episodes after MI have prognostic 
importance rather than severity of CAD [13]. Anxiety and depression 
may affect health-related behaviors such as smoking, tobacco abuse, 
alcohol consumption, diet, or physical activity, which in turn may 
influence the risk of coronary heart disease [14]. Many studies provide 
compelling evidence that psychosocial factors, particularly anxiety, 
depression and social support, are independent etiological and 
prognostic factors for occurrence of coronary heart disease. The relation 
between depression, anxiety and coronary heart disease differs from 
those of other psychosocial factors for several reasons. Depression and 
anxiety may cause direct acute or chronic patho physiological changes.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Anxiety, depression and associated disturbed quality of life (QoL) has 
been observed in a patient with PTCA for CAD. It is also noted that anxiety 
and depression are risk factors for the angina. Negative emotions play 
an important role in producing anxiety and depression [15].
Depression in cardiac patients is often both chronic and recurrent, 
and it is common among this patient, incidence is approximately 15% 
including those suffering acute coronary syndrome (ACS) and higher 
when compared to general population (4-5%) or primary care patients 
(8-10%) [16-18].
Depression and anxiety occur at high rates among patients suffering 
an ACS. Both depressive symptoms and anxiety appear to adversely 
affect in-hospital and long-term cardiac outcomes of post-ACS patients, 
independent of traditional risk factors. Despite their high prevalence 
and serious impact, mood and anxiety symptoms go unrecognized 
and untreated in most ACS patients and such symptoms (rather than 
being transient reactions to ACS) persist for months and beyond. The 
mechanisms by which depression and anxiety are linked to these 
negative medical outcomes are likely a combination of the effects 
of these conditions on inflammation, catecholamine’s, heart rate 
variability, and endothelial function, along with effects on health 
promoting behavior [19-24].
Weight change after coronary angioplasty could affect the path of the 
disease, very few studies have assessed the effects of weight change 
on outcomes after coronary angioplasty. Furthermore, there are very 
few studies that have examined the role of psychosocial reaction such 
as depression and anxiety on this issue. Post-operative anxiety and 
depression are well established and are consider as psychological 
reactions which can see during as well as after the angioplasty [25]. 
However, there are no definite studies have been conducted to see the 
association between the post PTCA weight loss and post angioplasty 
behavioral changes such as anxiety and depression.
This analysis was undertaken to evaluate the magnitude, direction, and 
determinants of weight change following coronary angioplasty and its 
relationship to depression and anxiety.
METHODS
A total of 1001 patients between 18 and 65 years of age who underwent 
PTCA in Kasturba Medical College and Hospital, Manipal, Karnataka, 
India, for ACS as well as CAD were included in this prospective 
study. Patients with moderate or severe left ventricular dysfunction 
(ejection fraction<40%), cardiogenic shock on presentation/during 
hospitalization, chronic kidney disease, known psychiatric illness 
on medications diagnosed by physician and/or noted in the medical 
record, psychological disturbances  and undergoing counseling or 
treatment for anxiety and depression, chronic liver disease, pregnant 
women, terminal malignancy patients with life expectation <1 year and 
patients with viral markers  positive were excluded.
Details of the study were explained in patients own language and 
informed consent was taken from them. Demographic data that 
included age, gender, marital status, educational level, height, and 
weight were obtained. Body mass index (BMI) was calculated. To control 
for extraneous factors, we recorded smoking history, family history and 
pre-existing cardiovascular risk factors such as presence of diabetes, 
hypercholesterolemia, and hypertension. This medication and different 
bio-chemical reports were collected along with electrocardiogram, 
coronary angiogram, and coronary angioplasty (PTCA). The study 
was conducted prospectively, material and data were collected during 
hospitalization and on 1 month follow-up. Results were documented in a 
customized form or form designed by organization, containing complete 
details of patient’s medications and investigations. On discharge, patient 
will be asked to come for follow-up on 1 month with investigation 
reports including fasting blood sugar, fasting lipid profile, and serum 
creatinine. On follow-up, documented the blood pressure and blood 
test reports of the patients and also assess the baseline characteristics 
including comorbidities, and anthropometry measurements, weight of 
the patients was measured. Assessment of psychological behavior such 
as anxiety and depression was done using the Euro groups standardized 
EQ-5D-5L-self-assessment QoL questionnaire downloaded from www.
euroqol.org after getting prior permission. Euro-EQ-5D-5L contains five 
self-assessment questionnaire in anxiety/depression column reporting 
level 1 (no anxiety/depression), level 2 (mild anxiety/depression), level 
3 (moderate anxiety/depression), level 4 (severe anxiety/depression), 
and level 5 (extreme anxiety/depression) [26].
RESULTS
There was significant decrease in mean body weight 1 month after 
PTCA (64.18±11.088 vs. 61.98±11.19, p<0.001) (Table 1).
Psychological reactions like anxiety, depression after 1 month was 
64.9%, viz., mild anxiety, depression was 47.5%, moderate anxiety, 
depression was 15.4% and severe/extreme anxiety, and depression 
was 2% of subjects. Among study population 71.81% subjects had lost 
their weight, 19.88% gained weight, and 8.31% had no changes in their 
weight 1 month after PTCA.
However, no significant association was found between weight changes 
and anxiety, depression in post coronary angioplasty patients (p=0.5) 
(Fig. 1).
In 1 month 7.8% of post PTCA patients had major adverse cardiac 
events (MACE) among this 2% had sudden cardiac death (SCD) and 5% 
had nonfatal MACE here also no association observed between weight 
change group and MACE (p=0.92) (Fig. 2), but there was a significant 
association between the anxiety, depression and MACE (p<0.001) 
(Fig. 3).
Table 1: Comparison of baseline and 1 month follow-up in 
overall study populations clinical and biochemical parameters
Parameters Mean±SD
Baseline Follow-up p value
Weight (kg) 64.18±11 61.9±11 <0.001
BMI (kg/m2) 23.8±4 23.7±10 0.671
SBP (mm of Hg) 132±20 131±20 0.05
DBP (mm of Hg) 82±12 81±10 0.371
Glycosylated Hb 7±2 7±2 0.017
BMI: Body mass index, SBP: Systolic blood pressure, DBP: Diastolic blood 
pressure, SD: Standard deviation
Fig. 1: Association between anxiety, depression and weight loss 1 
month after coronary angioplasty
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DISCUSSION
Many studies indicate that mean weight does not change after 
AMI [27,28]. However, in our study, there was a significant decrease 
in mean weight when compared to baseline weight; weight loss was 
associated with more comorbidities at baseline, suggesting weight 
loss might be a marker of coronary vascular disease (CVD), severity 
or poorer overall health. Weight loss may also be the result of lifestyle 
changes such as improved diet pattern, physical exercise, cessation 
of smoking/tobacco, optimum control blood cholesterol level, blood 
pressure, and blood sugar along with compliance with prescribed 
medication. Measurement of the rates of adherence to lifestyle changes 
and medications together with the identification of its determinants 
is of utmost importance for the design and provision of health 
education [29].
Although this study evidenced variation in weight and altered 
psychological reactions, there was no significant association found 
between these two outcomes. Weight loss also did not show significant 
association with MACE, whereas presence of anxiety, depression 
regardless of its severity had significant association with occurrence 
of MACE (p<0.01). This reveals that one’s psychological status plays 
significant role in prognosis after PTCA, wherein predischarge 
counseling may have impact on psychological status.
Enriched cohort study explains that there is definite weight loss after 
MI but there is no association between psychological behavior such 
as depression and social support and weight loss. However, weight 
loss was not associated with SCD and nonfatal MI [30]. Our study also 
explains the same, there is no association found between SCD, nonfatal 
MI and weight loss. Remarkable weight loss was found in patients 
1 year after bariatric surgery however, baseline depression and anxiety 
are not a predictors of post-surgical weight loss [31,32]. In addition, 
treating baseline anxiety/depression disorder might result in better 
QoL after surgery [32].
Post coronary angioplasty weight loss may be intentional or 
unintentional. If weight loss is intentional, it might be that awareness 
about post angioplasty health care and modification in lifestyle 
including healthy diet: Use of Mediterranean diet, omega-3 fatty acids, 
and physical exercise (30 minutes’ walk at least 5 days in a week) are 
come into play [33].
Prospective cohort studies unhealthy populations strongly confirm that 
depression and anxiety are possible etiological and prognostic factor 
for coronary heart disease and adverse cardiac events like SCD [32].
Weight loss and weight gain are associated with depression and 
anxiety in non-cardiac area, most of antipsychotic medication induces 
obesity, is also leads to depression/anxiety, particularly if severe [34]. 
We hypothesized that depression, anxiety would be related to weight 
change in post coronary angioplasty patients because anxiety and 
depression are associated with adverse events after PTCA. However, 
depression, anxiety did not interact with weight loss at baseline or 
weight related rates of adverse events or survival.
Given the graded relation between depression scores and risk, the long-
lasting nature of the effect, and the stability of the depression measured 
across time, it has been proposed that depression is a continuously 
distributed chronic psychological characteristic and anxiety is part of 
it [35], hence it is important to treat the both dynamically to avoid post 
angioplasty risks.
CONCLUSION
In our study, post angioplasty weight loss was significant comparing to 
baseline and mild to moderate anxiety and depression noted in the study 
population, even though not associated with weight loss 1 month after 
coronary angioplasty, weight loss may be controlled post angioplasty 
diet, regular physical exercise, and cessation of smoking/tobacco. Even 
though no association found between weight loss and MACE in 1 month 
follow-up but long term basis weight loss may influence the MACE, 
there for, one should not lose their weight aggressively.
Depression and anxiety are believed to be indirect risk factors for 
MACE, we found significant association between MACE and anxiety, 
depression, this group patients are less likely to follow a low-fat diet, 
lack of interest in physical exercise, cessation of smoking/tobacco and 
to reduce their cholesterol, blood pressure, blood sugar or reduce 
stress in their lives and all of which increase their recurrent cardiac 
event. Depression and anxiety patients less likely to maintain their 
routine normal health and less likely to attend cardiac rehabilitation 
programs, both of which important to prevent secondary cardiac risk 
as well as adverse cardiac outcome. In sum, depression and anxiety 
have innumerable effects on cardiovascular physiology via different 
mechanism and may lead different cardiac pathology so proper 
counseling will be effective in this group of patient to maintain their 
long-term eventless post angioplasty health. It is hoped that factors 
which hinder a better understanding of patient counseling, shall 
be identified with the goal of improving the patient adherence/
compliance and satisfying today’s need [36]. Several studies proved 
the importance of counseling to improve the patients’ understanding 
and adherence to their prescribed medications [37]. 
Fig. 2: Association between major adverse cardiac events and 
anxiety, depression 1 month post percutaneous transluminal 
coronary angioplasty
Fig. 3: Association between weight loss and major adverse cardiac 
events 1 month after coronary angioplasty
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Limitations of the study
Our findings underscore the need for clinical trials using these measures 
to test the effects of intentional or unintentional weight loss in patients 
with obesity and cardiovascular disease. We only used weight but 
waist-hip circumference is more identical to calculate the weight loss 
in cardiovascular disease. Our follow-up confined to only 1 month to 
see association between weight, anxiety and depression and to see the 
occurrence of the MACE.
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